Gliaton solution for injections 250 mg/ml. 4 ml. ampoules №5

Description

Gliaton Composition

active substance: choline alfoscerate 1 ml choline alfoscerate in terms of 100% substance 250 mg
excipients: water for injection.

Gliaton Dosage form

Injection.

Gliaton Pharmacological group

Drugs affecting the nervous system. Parasympathomimetics. Choline alfoscerate. ATC code N07A X02.

Indications

Acute period of severe traumatic brain injury with a predominantly stem level of damage (impaired consciousness, coma, focal HEMISPHERAL symptoms, symptoms of damage to the brain stem).

Degenerative-involutional brain psychoorganic syndromes or secondary consequences of cerebrovascular insufficiency, that is, primary and secondary disorders of mental activity in the elderly, characterized by memory impairment, confusion, disorientation, decreased motivation and initiative, decreased ability to concentrate, changes in the emotional sphere and behavior: emotional instability, irritability, indifference to the environment, pseudomelancholia in the elderly.

Contraindications

Hypersensitivity to the drug or to its components.

Patients with psychosomatic syndrome, with severe psychomotor agitation.

During pregnancy and breastfeeding.

Method of administration and dosage

In acute conditions, Gliaton is injected intramuscularly or intravenously slowly, 1 g (1 ampoule) for 15-20 days.

After stabilization of the patient’s condition, switch to oral forms of choline alfoscerate.

Overdose

In case of an overdose with Gliaton, which may manifest itself as nausea, anxiety, agitation, insomnia, the dose of the drug should be reduced. Features of the application.